podophyllotoxin has been researched along with cardiovascular agents in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Axelson, M; Girnita, L; Hedin, U; Henderson, B; Larsson, O; Razuvaev, A; Roy, J | 1 |
1 other study(ies) available for podophyllotoxin and cardiovascular agents
| Article | Year |
|---|---|
The cyclolignan picropodophyllin attenuates intimal hyperplasia after rat carotid balloon injury by blocking insulin-like growth factor-1 receptor signaling.
Topics: Animals; Apoptosis; Cardiovascular Agents; Carotid Artery Injuries; Catheterization; Cell Proliferation; Disease Models, Animal; Dose-Response Relationship, Drug; Hyperplasia; Insulin-Like Growth Factor I; Male; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Muscle, Smooth, Vascular; Phosphorylation; Podophyllotoxin; Proto-Oncogene Proteins c-akt; Rats; Rats, Sprague-Dawley; Receptor, IGF Type 1; Signal Transduction; Time Factors; Tunica Intima | 2007 |